620 related articles for article (PubMed ID: 28714799)
41. Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.
Kumar R; Son M; Bavi R; Lee Y; Park C; Arulalapperumal V; Cao GP; Kim HH; Suh JK; Kim YS; Kwon YJ; Lee KW
Acta Pharmacol Sin; 2015 Aug; 36(8):998-1012. PubMed ID: 26051108
[TBL] [Abstract][Full Text] [Related]
42.
Liu J; Feng K; Ren Y
J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
[TBL] [Abstract][Full Text] [Related]
43. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
Tripuraneni NS; Azam MA
J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
[TBL] [Abstract][Full Text] [Related]
44. Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition.
C P A; Subhramanian S; Sizochenko N; Melge AR; Leszczynski J; Mohan CG
J Biomol Struct Dyn; 2019 Apr; 37(6):1582-1596. PubMed ID: 29633917
[TBL] [Abstract][Full Text] [Related]
45. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
[TBL] [Abstract][Full Text] [Related]
46. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
[TBL] [Abstract][Full Text] [Related]
47. Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening.
Durai P; Ko YJ; Pan CH; Park K
BMC Bioinformatics; 2020 Jul; 21(1):309. PubMed ID: 32664863
[TBL] [Abstract][Full Text] [Related]
48. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
49. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
[TBL] [Abstract][Full Text] [Related]
50. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
Shah BM; Modi P; Trivedi P
J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
[TBL] [Abstract][Full Text] [Related]
51. Discovery of Camptothecin Based Topoisomerase I Inhibitors: Identification Using an Atom Based 3D-QSAR, Pharmacophore Modeling, Virtual Screening and Molecular Docking Approach.
Dev S; Dhaneshwar SR; Mathew B
Comb Chem High Throughput Screen; 2016; 19(9):752-763. PubMed ID: 27515040
[TBL] [Abstract][Full Text] [Related]
52. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
Lee S; Barron MG
Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
[TBL] [Abstract][Full Text] [Related]
53. Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches.
Selvakumar R; Anantha Krishnan D; Ramakrishnan C; Velmurugan D; Gunasekaran K
J Biomol Struct Dyn; 2020 Feb; 38(3):682-696. PubMed ID: 30806580
[TBL] [Abstract][Full Text] [Related]
54. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
Marondedze EF; Govender KK; Govender PP
J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
[TBL] [Abstract][Full Text] [Related]
55. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
[TBL] [Abstract][Full Text] [Related]
56. Discovery of small molecule inhibitors through pharmacophore modeling, molecular docking, molecular dynamics simulation and experimental validation against myeloid cell leukemia-1 (Mcl-1).
Suleiman MR; Wang H; Huang D; Wang H; Joseph J; Huang T; Zhang F; Wang J; Cheng M
J Biomol Struct Dyn; 2021 Apr; 39(7):2512-2525. PubMed ID: 32228162
[TBL] [Abstract][Full Text] [Related]
57. 3D pharmacophore mapping using 4D QSAR analysis for the cytotoxicity of lamellarins against human hormone-dependent T47D breast cancer cells.
Thipnate P; Liu J; Hannongbua S; Hopfinger AJ
J Chem Inf Model; 2009 Oct; 49(10):2312-22. PubMed ID: 19799437
[TBL] [Abstract][Full Text] [Related]
58. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
Xia YL; Wang JJ; Li SY; Liu Y; Gonzalez FJ; Wang P; Ge GB
Bioorg Med Chem; 2021 Jan; 29():115851. PubMed ID: 33218896
[TBL] [Abstract][Full Text] [Related]
60. Exploration of Novel Inhibitors for Bruton's Tyrosine Kinase by 3D QSAR Modeling and Molecular Dynamics Simulation.
Bavi R; Kumar R; Choi L; Woo Lee K
PLoS One; 2016; 11(1):e0147190. PubMed ID: 26784025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]